KURA ONCOLOGY, INC. — Form D
KURA ONCOLOGY, INC. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-23. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-23
- Form: D
- Accession: 0001631246-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 23
- Date of first sale: 2015-01-12
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-232788
Issuer
- Name: KURA ONCOLOGY, INC.
- CIK: 0001631246
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 11119 N TORREY PINES RD STE 125, LA JOLLA, CA, 92037
- Phone: 858-500-8835
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Troy Wilson | Director | San Francisco, CA |
| Troy Wilson | Executive Officer | San Francisco, CA |
| Heidi Henson | Executive Officer | Seattle, WA |
| Yi Liu | Executive Officer | NEW YORK, NY |
| Pingda Ren | Executive Officer | San Diego, CA |
| ANNETTE NORTH | Executive Officer | LA JOLLA, CA |
| ANTONIO GUALBERTO | Executive Officer | LA JOLLA, CA |
Other filings by this issuer (1)
More